Valgimigli, Marco <br/><br/>
Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells: a possible link to pan-coronary syndromes.  [electronic resource] 

 -  Circulation  Jan 2003 
 - 264-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.0000045665.57256.86  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Angina Pectoris--blood<br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, CD--blood<br/>Antioxidants--pharmacology<br/>Apoptosis--drug effects<br/>Blood Proteins--pharmacology<br/>Cells, Cultured<br/>Chromans--pharmacology<br/>Coronary Angiography<br/>Coronary Disease--blood<br/>Endothelium, Vascular--cytology<br/>Female<br/>Humans<br/>Interleukin 1 Receptor Antagonist Protein<br/>Interleukin-6--antagonists & inhibitors<br/>Lipoproteins, LDL--blood<br/>Male<br/>Middle Aged<br/>Proto-Oncogene Proteins--biosynthesis<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>Receptors, Tumor Necrosis Factor--blood<br/>Receptors, Tumor Necrosis Factor, Type I<br/>Receptors, Tumor Necrosis Factor, Type II<br/>Sialoglycoproteins--blood<br/>Tumor Necrosis Factor-alpha--analysis<br/>bcl-2-Associated X Protein<br/>fas Receptor--biosynthesis